Geron (GERN) Interest Expenses (2010 - 2026)
Geron (GERN) posted Interest Expenses of $7.1 million for Q1 2026, down 2.06% sequentially from $7.3 million in Q4 2025, and down 12.84% YoY from $8.2 million in Q1 2025.
Geron (GERN) Interest Expenses (2010 - 2026) Analysis & Trends
Geron has reported Interest Expenses for 17 years, with the latest figure at $7.1 million in Q1 2026.
- Quarterly Interest Expenses fell 12.84% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.6 million (up 35.81% YoY) and the FY2025 annual result came in at $444.6 million, up 3.43% from the prior year.
- Interest Expenses slipped to $7.1 million in Q1 2026 per GERN's latest filing, from $7.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $8.7 million in Q4 2024 and troughed at $277000.0 in Q4 2022.
- A 5-year average of $4.1 million and a median of $3.0 million in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses sank 80.0% in 2022, then surged 748.54% in 2024.
- Over 5 years, Interest Expenses stood at $277000.0 in 2022, then surged by 270.4% to $1.0 million in 2023, then soared by 748.54% to $8.7 million in 2024, then decreased by 16.18% to $7.3 million in 2025, then dropped by 2.06% to $7.1 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $7.1 million, $7.3 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | 7.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.15 Mn |
| Jun 30, 2026 | 7.15 Mn |
| Mar 31, 2026 | 7.15 Mn |
| Mar 31, 2026 | 7.15 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Sep 30, 2025 | 8.64 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 8.20 Mn |
| Mar 31, 2025 | 8.20 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Dec 31, 2024 | 8.71 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 3.32 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Mar 31, 2024 | 3.43 Mn |